Major Acquisition in Medical IT Sector: AIIS Acquires ISM
In a significant development in the medical information technology sector, AIIS (Artificial Intelligence and Information Systems), a consolidated subsidiary, has completed its acquisition of a substantial majority stake in ISM (Information Systems Management). This move, finalized on July 1, 2025, is seen as a strategic step to build a formidable network in the healthcare sector across Japan.
Overview of the Acquisition
On May 26, 2025, during a board meeting held in Fukuoka, AIIS made the strategic decision to acquire 81% of ISM's outstanding shares. The decision came as part of a broader plan to enhance the company’s operational efficiency and profitability through consolidation. This acquisition allows AIIS to integrate ISM's established distribution channels and supplier relationships directly into its organizational framework.
ISM, headquartered in Fukuoka City, and led by CEO Toshihide Isami, has been a key player in medical software development, providing tailored solutions that cater to over 800 medical institutions. The company's focus on delivering the popular Mighty Checker series underlines its importance in the industry.
Future Strategic Plans
The decision to acquire ISM is considered a cornerstone in AIIS's national expansion strategy, aimed at forming partnerships with strong regional players across Japan’s healthcare network. President and Chairman Masayuki Aoki stated that the collaboration is poised to accelerate growth while improving financial performance on a consolidated basis. AIIS is focused on fostering a robust and effective business operation model, directly embedding ISM's well-rooted distribution and agency functions into its framework.
This merger is expected to lead to significant revenue growth and enhance profitability, thereby solidifying a robust economic foundation for the shareholders. As the integrated operations unfold, AIIS will continuously maintain a commitment to strategic investments and organizational restructuring designed to maintain its status as a leading company in the healthcare sector.
Company Profiles
1.
ISM Inc.
-
Location: 2-6-10-102 Mukuno, Minami-ku, Fukuoka City, Fukuoka Prefecture
-
Founded: October 2010
-
CEO: Toshihide Isami
-
Business: Medical software development and consulting
-
Capital: ¥5 million
-
Website:
ISM
2.
AIIS Inc.
-
Location: 21 Ichibancho, Chiyoda, Tokyo
-
Founded: December 8, 2005
-
CEO: Masayuki Aoki
-
Business: Technology solutions for medical institutions, including consulting and data analytics.
-
Website:
AIIS
Looking Ahead
As a result of the acquisition, ISM will now be an integral part of AIIS, with its performance expected to contribute positively to the company’s consolidated financial results starting from the second quarter of the fiscal year ending March 2026. The integration of ISM's growth potential with AIIS's managerial resources is anticipated to pave the way for increased profitability and enhanced corporate value for the entire group.
AIIS is committed to providing timely updates on the impact of this acquisition as important details are confirmed. This alignment positions AIIS to not only maintain its leadership but also focuses on maximizing sustainable corporate value in the rapidly evolving medical services sector.